Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. - Wikidata - awgldk - TriplyDB

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.

http://www.wikidata.org/entity/Q30496676

about

Blood alpha-synuclein in agricultural pesticide handlers in central Washington State Modeling Parkinson's disease in the common marmoset (Callithrix jacchus): overview of models, methods, and animal care Emerging candidate biomarkers for Parkinson's disease: a review Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype Alpha-Synuclein in Parkinson's Disease: From Pathogenetic Dysfunction to Potential Clinical Application Decrease in plasma levels of α-synuclein is evident in patients with Parkinson's disease after elimination of heterophilic antibody interference DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.Targeted discovery and validation of plasma biomarkers of Parkinson's disease.Towards translational therapies for multiple system atrophy Blood-based biomarkers for Parkinson's disease α-Synuclein and anti-α-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controls Naturally occurring alpha-synuclein autoantibodies in Parkinson's disease: sources of (error) variance in biomarker assays.Using gastrocnemius sEMG and plasma α-synuclein for the prediction of freezing of gait in Parkinson's disease patients.Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review.Accessing to the minor proteome of red blood cells through the influence of the nanoparticle surface properties on the corona composition.Alpha-synuclein levels in blood plasma decline with healthy aging.Serological Analysis of Alpha-synuclein and NF-κB in Parkinson's Disease Patients.Premotor biomarkers for Parkinson's disease - a promising direction of research.Altered Plasma Profile of Antioxidant Proteins as an Early Correlate of Pancreatic β Cell Dysfunction.Alpha-Synuclein Expression in Patients with Parkinson's Disease: A Clinician's Perspective.Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles.Up-regulation of SNCA gene expression: implications to synucleinopathies Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson's disease patients A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease.Dataset of total, oligomeric alpha-synuclein and hemoglobin levels in plasma in Parkinson׳s disease.α-Synuclein and DJ-1 as potential biological fluid biomarkers for Parkinson's Disease.Parkinson's disease--the continuing search for biomarkers.Biomarkers of Parkinson's disease: current status and future perspectives.New concepts in the early and preclinical detection of Parkinson's disease: therapeutic implications.Role of platelets in neurodegenerative diseases: a universal pathophysiology.Gender differences in Parkinson's disease: focus on plasma α-synuclein.Cerebrospinal fluid biomarker candidates for parkinsonian disorders.α-Synuclein and mitochondrial dysfunction in Parkinson's disease.Is there a need to redefine Parkinson's disease?New insight into neurodegeneration: the role of proteomics.Oxidized DJ-1 as a possible biomarker of Parkinson's disease Salivary proteomics and biomarkers in neurology and psychiatry.The Concept of Prodromal Parkinson's Disease.

P2860

Q23922069-E54D7487-BEAC-4E54-92A8-21049DD9852E Q26772285-11E97061-07A1-4394-A76B-B2ABC97DC552 Q27015018-B2E8563A-A84C-43D2-B7D6-04D3B72CCE6C Q27322563-A91142E3-F64E-477F-85F2-2818ED464E8C Q27333275-0E63609B-EF3A-41ED-8FA5-817C96512D2A Q28079911-D8C79467-6647-43DF-96A1-905816D5C48F Q28545821-9C5E02A2-C9B4-4747-AB77-DC57018CADF0 Q30529658-08BE9B3C-BE8A-4CDD-86B3-EDCA28FDFD94 Q30588544-04E663E5-F9CD-4307-86B5-43B64C61DDB1 Q30597182-F2A713FF-EEAA-4355-A2DB-FF18B4927D50 Q33797532-7DBCE57F-FCC8-4A62-984A-E8BBC9A400D4 Q33804255-5396724D-FFBF-417B-9529-DC30FDCAE421 Q34533573-1BE60821-D123-4BF2-9A5E-32426D61EB6A Q34627859-DD1DC199-5AAD-4B05-A039-690A6A59D409 Q35107114-13FDDB07-5B95-4E48-9AD2-EFBAB1FA6306 Q35139572-984F6045-B33A-4AE3-82AB-1C5772B89133 Q35174085-FF407224-C5A2-4162-8274-7390576212C5 Q35284843-F1FE4D31-C078-4839-AFCA-FBDF0ED3C9EE Q35792286-D6CFE0C3-ECD5-474C-B892-4B0CD872B9F1 Q36444517-011F06D0-DAF2-4334-82FB-0FD14C6D851D Q36850046-C193DAC6-8CB4-427B-95F3-91998FB463D6 Q36976868-D2C943FA-C392-461E-BC7E-49B7AE3CC448 Q36982173-D763E15D-B0AB-4FD3-98FA-D09590FBBB2A Q37004246-9E661CEC-716A-4C4F-ADF8-5A68A52ED5CE Q37030864-28A885A8-9BF9-4476-9B0F-E695961D91FD Q37129697-E1E872BC-FFAE-4DBD-B4BA-1301F36F02CA Q37491380-2D1B225A-35EA-4F2A-9203-94432612FA5F Q37820120-F31BA663-6BF8-42C2-B4D8-F5EBF4DAA251 Q37834648-2B6B6623-6B15-48FC-8835-D085EC935C0C Q38043841-B49043EB-25D3-4BC2-A407-EA5903A1DD39 Q38067141-2076CB6E-497E-40CA-A74A-F3FE9196EA26 Q38072757-1AD95FB7-6A94-48EB-88C2-EB192B7FAABF Q38074839-0F63430C-D766-4ED3-AE2C-A1B95CEEBC26 Q38076411-EE64B1DD-C8D1-4F4F-9BF9-E9A260F7C0A3 Q38077665-9A479E26-35E2-4875-822A-B8EAD8A527AC Q38110209-00568C97-FB03-4675-87B0-A5040C0520E4 Q38170010-FA31C77A-BDE8-46D0-80DB-0F07E752A0F3 Q38217361-E3E958B2-569E-471A-8EC1-E6EB490F51EB Q38335930-63511EA0-5D29-4FD6-B1A1-C71BA3111BBA Q38612230-DD6A4A19-6AC4-4C08-BB1D-74222D976F85

P2860

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.

http://www.wikidata.org/entity/Q30496676

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Significance and confounders o ...... uclein in Parkinson's disease.

@ast

Significance and confounders o ...... uclein in Parkinson's disease.

@en

type

label

Significance and confounders o ...... uclein in Parkinson's disease.

@ast

Significance and confounders o ...... uclein in Parkinson's disease.

@en

prefLabel

Significance and confounders o ...... uclein in Parkinson's disease.

@ast

Significance and confounders o ...... uclein in Parkinson's disease.

@en

P1433

Q30496676-4F783482-6860-476C-BD5D-01CA713F6F06

P1476

Q30496676-D00D8786-1CF5-478A-A6A5-EC5E5103B139

P2093

Q30496676-811A9E8E-109F-408C-9C6D-CC0FDC2E6682

Q30496676-839569D3-622E-4FDF-A053-DE04F64F3634

Q30496676-84B3F345-E741-436F-9AC2-5579770C97FC

Q30496676-ADB8BC11-BA9D-4ACD-A249-A9F1E12EEB41

Q30496676-ADF83437-8516-4449-9B34-AA42FDB10F08

Q30496676-B479B45E-63A0-4FE0-BD27-121AB2EA9A7D

Q30496676-CE355722-6312-4FC5-9BFA-EA4E462C73E2

Q30496676-EF4A0E73-283E-4C33-B0B6-420B51C3F0F2

Q30496676-F3FE3C8E-F344-48A7-BA33-CB1D835C726B

P2860

Q30496676-0D91789B-CF53-4CBD-A4EA-4283B5C17078

Q30496676-356AC885-D56C-4AAC-AA6D-E4E7C1868819

Q30496676-38BF4881-EDD6-437F-A5C6-12437CE0156B

Q30496676-44D99D76-DA40-46B6-82C1-A6B385F17CC0

Q30496676-671A0948-7D0B-4425-B310-B87D9D042AA5

Q30496676-7930C533-88F3-424E-8F7C-0C10F64BA01A

Q30496676-7C36628C-3870-4B76-A2A8-EF4F030AB8BB

Q30496676-AA6964E6-C96D-44BC-B10F-CBD1B2AAB78B

Q30496676-B904033A-3320-4DC7-89B7-2365D8984C1B

Q30496676-C56965F6-8463-4F34-B426-9A424F992ABC

P304

Q30496676-BE190D32-6955-463D-BA15-F0A4E53426E4

P31

Q30496676-5CFB6BD5-77AA-4379-9F92-EB6F171DD0A4

P356

Q30496676-7AEA8ECD-659D-46F6-9268-A3CF02FFCAED

P407

Q30496676-EA54EDE0-14ED-4EF4-90C1-5450A99D8C14

P433

Q30496676-3FF84D0E-8121-41F1-8D90-B6A642A29619

P478

Q30496676-216860D5-8F81-4532-BE66-18F9B25E5F3B

P50

Q30496676-849FE3A8-74A2-4BD5-95B3-051B3EDE618B

Q30496676-96DCB7CE-993B-44CC-8DE5-7C413918624D

Q30496676-A3CE69EA-8B12-4326-A428-F090341F725D

Q30496676-D7C8B7DA-42E8-46B2-BC92-404B267EE4B3

P577

Q30496676-5F6C190A-FA8A-4609-A797-92AF07D6C66A

P5875

Q30496676-01D7FB62-AB76-4141-BB5B-AB0881A553F2

P698

Q30496676-95A53FA8-0D18-4926-8D3C-7E77D0BAFFF6

P921

Q30496676-8A0BE838-CBF6-4E51-9309-2A8E2471CCBB

Q30496676-FD49F0BC-7968-403F-A4CC-7F8F89EF3EDC

P932

Q30496676-D5ED20F3-781E-4495-A46D-3873FBDA1026

P356

J.NEULET.2010.06.009

P1433

Neuroscience Letters

P1476

Significance and confounders o ...... nuclein in Parkinson's disease

@en

P2093

Aneeka M Hancock

http://www.w3.org/2001/XMLSchema#string

Carmen Ginghina

http://www.w3.org/2001/XMLSchema#string

Dora Yearout

http://www.w3.org/2001/XMLSchema#string

Douglas Galasko

http://www.w3.org/2001/XMLSchema#string

Elaine R Peskind

http://www.w3.org/2001/XMLSchema#string

Jing Zhang

http://www.w3.org/2001/XMLSchema#string

Joseph Jankovic

http://www.w3.org/2001/XMLSchema#string

Kathryn A Chung

http://www.w3.org/2001/XMLSchema#string

Zhen Hong

http://www.w3.org/2001/XMLSchema#string

P2860

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

Platelet alpha- and gamma-synucleins in Parkinson's disease and normal control subjects.

Neuropathological spectrum of synucleinopathies.

The etiopathogenesis of Parkinson disease and suggestions for future research. Part I.

Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patients.

DJ-1, a causative gene product of a familial form of Parkinson's disease, is secreted through microdomains.

Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration.

Determination of alpha-synuclein concentration in human plasma using ELISA.

Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease.

Plasma alpha-synuclein in patients with Parkinson's disease with and without treatment.

P304

78-82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEULET.2010.06.009

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

480

http://www.w3.org/2001/XMLSchema#string

P50

Cyrus P Zabetian

James B Leverenz

P577

2010-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44666374

http://www.w3.org/2001/XMLSchema#string

P698

20540987

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

2943649

http://www.w3.org/2001/XMLSchema#string